Trial Profile

A phase II study to determine the efficacy and safety of conventional dose oral treosulfan in patients with advanced pre-treated Ewings sarcoma.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Treosulfan (Primary)
Indications Ewing's sarcoma
Focus Therapeutic Use
Acronyms OTIS

Most Recent Events

05 Aug 2019 Status changed from active, no longer recruiting to completed.
19 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by UKCRN.
09 Sep 2012 Planned End Date changed from 31 Aug 2012 to 14 Sep 2012 as reported by United Kingdom Clinical Research Network.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com